Inhibition of IgE‐dependent histamine release from human dispersed lung mast cells by anti‐allergic drugs and salbutamol

British Journal of Pharmacology - Tập 90 Số 2 - Trang 421-429 - 1987
Martin K. Church1,2, Jun Hiroi1,2
1Clinical Pharmacology, Centre Block, Southampton General Hospital, Southampton SO9 4XY
2Department of Pharmacology, Research Laboratories, Fujisawa Pharmaceutical Co. Ltd, 1-6 Kashima 2-chome, Yodogawaku, Osaka 532, Japan.

Tóm tắt

The ability of the anti‐allergic drugs, sodium cromoglycate (SCG), lodoxamide, traxanox, RU31156 and the β‐adrenoceptor agonist sulbutamol to inhibit IgE‐dependent histamine and prostaglandin D2 (PGD2) release was assessed using human dispersed lung mast cells. The anti‐allergic drugs were weak inhibitors of histamine release, high concentrations (100–1000 μm) producing < 35% inhibition. Salbutamol produced 39% inhibition at 10 μm. The efficacy of both SCG and salbutamol was inversely related to the concentration of anti‐IgE used for challenge and to the degree of histamine release. Rapid tachyphylaxis was observed with all anti‐allergic drugs but not with salbutamol. Cross‐tachyphylaxis was observed between SCG and the other anti‐allergic drugs, suggesting a common mechanism of action. No cross‐tachyphylaxis was observed between SCG and salbutamol. SCG was significantly (P < 0.001) more effective in inhibiting PGD2 than it was histamine release. Preferential inhibition of PGD2 compared with histamine release was less marked (P < 0.05) with salbutamol and not significant with the other anti‐allergic drugs. Mast cells dispersed by enzymatic digestion of human lung released more histamine on immunological challenge than mechanically dispersed cells obtained by fine chopping of tissue. Enzyme treatment of mechanically dispersed cells removed this difference. Enzymatically and mechanically dispersed cells responded similarly to the inhibitory effects of SCG and salbutamol. Our results suggest that salbutamol is a more effective inhibitor of mediator release from human lung mast cells than anti‐allergic drugs. However, with the low levels of mediator release achieved during an allergic reaction in man in vivo, both salbutamol and SCG are likely to be effective inhibitors of both preformed and newly generated mediators.

Từ khóa


Tài liệu tham khảo

Assem E.S.K., 1971, Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by β‐adrenergic stimulants and disodium cromoglycate, Immunology, 21, 729

10.1016/0091-6749(78)90099-4

10.1111/j.1476-5381.1979.tb16102.x

10.1159/000231509

10.1111/j.1365-2222.1982.tb02522.x

Church M.K., 1982, Characterization of histamine secretion from dispersed human lung mast cells: effects of anti‐IgE, calcium ionophore A23187, compound 48/80 and basic polypeptides, J. Immunol., 129, 2116, 10.4049/jimmunol.129.5.2116

10.1111/j.1476-5381.1983.tb09419.x

10.1111/j.1365-2222.1985.tb02999.x

10.1038/2161328a0

10.1159/000192762

10.1016/0006-291X(83)90337-6

Fitzpatrick F.A., 1983, Albumin‐catalysed metabolism of prostaglandin D2 identification of products formed in vitro, J. biol. Chem., 258, 11713, 10.1016/S0021-9258(17)44287-6

10.1042/cs0680427

Goose J., 1969, Passive cutaneous anaphylaxis in the rat induced by two homologous reagin‐like antibody sera and its specific inhibition with disodium cromoglycate, Immunology, 16, 749

10.1159/000232234

10.1056/NEJM198407263110401

Holgate S.T., 1984, Anaphylactic and calcium dependent generation of prostaglandin D2 (PGD2), thromboxane B2 and other cyclo‐oxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release, J. Immunol., 133, 2138, 10.4049/jimmunol.133.4.2138

Howarth P.H., 1985, Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to antigen bronchial provocation in asthma, Am. Rev. Respir. Dis., 132, 986

Johnson A.R., 1970, Inhibition of the release of histamine from rat mast cells: the effect of cold and adrenergic drugs on release of histamine by compound 48/80 and antigen, J. Pharmac. exp. Ther., 175, 632

10.1159/000232051

10.1111/j.1365-2222.1973.tb01321.x

Leung K.B.P., 1985, A comparison of histamine secretion from human basophils and from human lung mast cells obtained by bronchoalveolar lavage (BAL) and from dispersion of lung fragments, Clin. Sci., 68, 7P, 10.1042/cs068007Pa

Lichtenstein L.M., 1971, The immediate allergic response: in vitro action of cyclic AMP‐active and other drugs on the two stages of histamine release, J. Immunol., 107, 1131, 10.4049/jimmunol.107.4.1131

10.1172/JCI110670

10.1016/0091-6749(85)90808-5

Marquardt D.L., 1982, Characterization of rat mast cell beta‐adrenergic receptor in resting and stimulated cells by radioligand binding, J. Immunol., 129, 2122, 10.4049/jimmunol.129.5.2122

10.1159/000231602

10.1016/0091-6749(80)90040-8

Miller P.(1976).Pinnal Anaphylaxis in The Mouse.PhD Thesis Council for National Academic Awards London pp.127–132.

Miller P., 1978, Inhibition of immediate hypersensitivity reactions by a novel xanthone, RU‐31, 156, Arch. int. Pharmacodyn. Ther., 231, 328

Pearce F.L., 1982, Mucosal mast cells. II. Effects of anti‐allergic compounds on histamine secretion by isolated intestinal mast cells, J. Immunol., 128, 2481, 10.4049/jimmunol.128.6.2481

Peters S.P., 1982, Dispersed human lung mast cells: pharmacologic aspects and comparison with human lung tissue fragments, Am. Rev. Respir. Dis., 126, 1034

10.1159/000231948

10.1159/000231949

10.1159/000231080

10.1126/science.6153130

10.1016/0091-6749(83)90540-7

Tung R., 1981, cAMP agonist inhibition increases at low levels of histamine release from human basophils, J. Pharmac. exp. Ther., 218, 642

10.1016/0091-6749(80)90023-8

10.1016/0006-2952(83)90585-3

10.1159/000233311